HGH Products With IGF-1 Clinical Studies

The products whose human growth hormone formulas have undergone double-blind placebo-controlled IGF-1 clinical trials to measure effectiveness are listed below. IGF-1 levels are used to measure the amount of human growth hormone in the body. If a brand is not listed below it's because that brand has not had any legitimate IGF-1 clinical studies to prove whether it can actually increase human growth hormone in the body.

ProBLEN (our Brand)

Physician Supervised Clinical Study Results (our clinical studies)

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
1- 21	23.2 ng/ml to 49.6 ng/ml	44.09 ng/ml to 114.5 ng/ml	Average +160.6%	5 Months

Overall Average IGF-1 Change: +160.6%
Clinical Studies by Dr. Juan Hernandez Flores, Lic., and Irais Castellanos Mungula, at the Centro Geriatrico Naturista, Mexico D.F. (click here for our clinical study specifics)

Nu-Spring*

Clinical Studies

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
1	112 on 12/17/96	206 on 5/27/97	+84%	161 Days
2	73 on 1/14/97	258 on 6/24/97	+253.4%	161 Days
3	123 on 1/22/97	188 on 3/25/97	+52.9%	62 Days
*4	115 on 1/31/97	218 on 5/27/97	+89.6%	116 Days
5	229 on 2/01/97	259 on 4/5/97	+13.1%	63 Days
6	142 on 2/4/97	264 on 5/31/97	+85.9%	116 Days
7	97 on 2/28/97	132 on 4/04/97	+36.1%	35 Days
8	131 on 3/15/97	247 on 5/16/97	+88.6%	62 Days
9-18	no information given for patients 9 - 18

Average Change: +105.8%
(FOD #619-824-3423 #7 - #14) (Total study included 18 people - average is of that total group)

*If you compare the results of Nu-Spring and PRO-Symbio Plus you will notice that it appears they reported some of the same results. For instance, Nu-Spring's patient 4 is identical to PRO-Symbio's patient 2. Perhaps both brands use the same formula.

PRO-Symbio PLUS*

Clinical Studies

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
1	106 on 04/18/97	203 on 05/27/97	+91.5%	39 Days
*2	115 on 01/31/97	218 on 05/27/97	+89.6%	116 Days
3	131 on 03/15/97	247 on 05/16/97	+88.6%	62 Days
4	115 on 1/31/97	259 on 04/05/97	+13.1%	63 Days
5	183 on 03/21/97	261 on 05/20/97	+42.6%	60 Days
6	36 on 04/08/97	101 on 05/30/97	+180.6%	52 Days
7	97 on 02/28/97	132 on 04/04/97	+36.1%	35 Days
8	142 on 02/04/97	264 on 05/31/97	+85.9%	116 Days

Overall Average Change: +105.8%
Overall Average Days: 68.6 days

Regenesis 1

Identical to LifeSpan I
Clinical Results

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
1	135 on 4/8/97	279 on 9/2/97	+74%	27 Days?
2	141 on 2/25/97	208 on 3/27/97	+34%	29 Days
3	72 on 4/5/97	195 on 6/5/97	+170%	63 Days
4	142 on 4/21/97	172 on 10/30/97	+21%	188 Days
5	176 on 4/10/97	185 on 10/24/97	+5%	192 Days
6	84 on 2/97	168 on 7/22/97	+100%	171 Days
7	167 on 4/10/97	185 on 10/24/97	+11%	192 Days
8	208 on 3/27/97	279 on 9/2/97	+34%	153 Days
9-23	No information given for patients #9 - #23

Average Change: +82.8%
(Total study included 23 people - average is of that total group)

Pro-hGH

Physician Supervised Clinical Studies

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
1	93 on 1/31/97	127 on 2/5/97	+37%	6 Days
2	73 on 1/14/97	141 on 2/25/97	+93%	11 Days
3	21 on 1/14/97	69 on 2/5/97	+229%	22 Days
4	110 on 1/18/97	180 on 2/4/97	+64%	18 Days
5	357 on 1/24/97	388 on 1/25/97	+8.5%	1 Day?
6	167 on 1/24/97	178 on 1/25/97	+7%	1 Day?
7	242 on 1/25/97	273 on 1/27/97	+12.5%	1 Day?
8	255 on 1/27/97	269 on 1/29/97	+5.5%	2 Days

Average Change: +57.06%

Rejuvamin

Clinical Study- Complete Results
REJUVAMIN QID 2 GRAMS - SIX WEEK DURATION

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change
1	106	241	+127.4%
2	120	200	+66.7%
3	146	276	+89.0%
4	124	165	+33.1%
5	162	225	+38.9%
6	108	196	+81.5%
7	182	241	+32.4%
8	124	208	+67.7%
9-12	No information given for patients 9 - 12

Average Change: +56.8%
(Total study included 12 people - average is of that total group) Clinical Study carried out by Dr. Timothy Bassett and Dr. Steven Smith at the LiFExtension Institute

Eden GH-1

Clinical Test Studies

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
1	167 on 1/13/97	186 on 2/12/97	+11%	31 Days
2	206 on 1/13/97	280 on 2/11/97	+36%	29 Days
3	174 on 1/17/97	185 on 2/20/97	+6%	34 Days
4	201 on 1/17/97	271 on 2/21/97	+35%	35 Days
5	212 on 1/20/97	286 on 2/24/97	+35%	26 Days
6	119 on 1/20/97	159 on 2/24/97	+34%	35 Days
7	142 on 1/20/97	190 on 2/27/97	+31%	38 Days
8	122 on 1/24/97	223 on 4/16/97	+83%	82 Days
9-35	No information given for patients 9 - 35

Average Change: +44.09%
(Total study included 35 people - average is of that total group)

Biogevity

Research Studies- In outcome based research studies performed on 20 subjects supplementing with BioGevity for up to 26 weeks, 75% of subjects (15 people) experienced a 41% average increase in IGF-1 levels (insulin-like growth factor-1, a stable indicator of Somatotropin levels).

Total Increases for 75% of Subjects: +41%
(results of 15 subjects given, results of other 5 subjects not given)

Other Brands of HGH Products

Patient	Pre IGF-1 Level	Post IGF-1 Level	% of Change	Length
None	None	None	None	None

 

The Specifics of our ProBLEN IGF-1 Clinical Studies.

Information About Proper IGF-1 Clinical Testing and the False or Misleading Reporting Some Use.

Our Pharmaceutical Lab's Survey of Clients Taking ProBLEN Human Growth Hormone.